Brought to you by 
Black Belt Therapeutics spins out of Tusk concurrent with acquisition by Roche
07 Oct 2020
Executive Summary
Concurrent with Roche’s acquisition of Tusk Therapeutics Ltd., Tusk spun out a new company called Black Belt Therapeutics to continue pursuing oncology candidates in Tusk’s pipeline.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
Deal Status
- Final
Deal Type
-
Acquisition
- Divestiture/Spin-Out
- Intra-Biotech Deal
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Black Belt Therapeutics spins out of Tusk concurrent with acquisition by Roche
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice